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Abstract
Toxicologists are often concerned with determining the dosage to which an individual can be exposed with
an acceptable risk of adverse effect. These types of studies have been conducted widely in the past, and many
novel approaches have been developed. Parametric techniques utilizing ANOVA and non-linear regression
models are well represented in the literature. The biggest drawback of parametric approaches is the need
to specify the correct model. Recently, there has been an interest in non-parametric approaches to tolerable
dosage estimation. In this work, we focus on the monotonically decreasing dose response model where the
response is a percent to control. This poses two constraints to the non-parametric approach. The dose-
response function must be one at control (dose=0), and the function must always be positive. Here we
propose a Bayesian solution to this problem using a novel class of non-parametric models. A basis function
developed in this research is the Alamri Monotonic spline (AM-spline). Our approach is illustrated using
two simulated data and two experimental dataset from pesticide related research at the US Environmental
Protection Agency.
KeyWords: Bayesian Statistics; Nonparametric modelling; Alamri Monotonic spline; Toxicology
data; Benchmark tolerable region
1. Introduction
Evaluating the risk of exposure to chemicals starts by measuring the side effects of chemical on an
experiment specimen, it is a critical step in pharmaceutical drug development and in other chem-
ical areas as well. Many toxicology studies are performed on rodents and in some cases require
sacrificing the rodent to get the endpoints measurement that indicates the level of chemical side
effects. Toxicologists are searching to develop methods that determine the dose which corresponds
to the research targeted dose-response effect. Are the chemical dangers at any dose or is there is a
specific limit of a safe dose? How much of the chemical can we consume without getting into the
bad side effect? These question motivate our research in developing new dose response model that
answer these question. Toxicologist goal is to find the safe dose with an acceptable side effect. The
literature introduced several methods that deal with dose-response determination. The Benchmark
dose (BMD) is a method to find the maximum tolerable dose that produces a prespecified acceptable
side effect level on the experimental specimen. Other methods, the No Observable Adverse Effect
Level (NOAEL) which means the highest dose at which there was no observed effect and the Low
Observed Adverse Effect Level (LOAEL) approach Crump [1984] and ?. There are many other
dose-response model threshold Crump [1984]. Which determine the safest dosage, the dangerous
dosage or any other inquiry. The method we consider in our research is the Effective Dose EDγ,
where γ is the level of side effects on the experiment specimen which could be 50%,75%,90% or
any other number of interest. ED50 specifically is the BMD type that we will use in this article,
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which is the dose that causes a 50% reduction in the average response. BMD is a favorable method
than NOAEL since it presumes the dose-response model shape that depends on the data more. For
more about benchmark dose estimation, see Shao and Shapiro [2018].
Most statistical methodology for dose-response studies has been using the parametric models
such as in Holland-Letz and Kopp-Schneider [2015], where they used the Log-normal function,
Log-logistic function; Exponential function, Gaussian function; Logistic function, Gompertz func-
tion and the Weibull function. In parametric model all the parameters are in finite-dimensional
parameter spaces. Fitting of the parametric dose-response model requires knowledge about the pa-
rameters of the model. More about parametric dose response model in ?, ? and ?. The parametric
model are flexible in fitting data when information about the parameters, data shape and type are
provided. That makes the parametric model struggle in fitting model to the unknown parameters or
unexpected data shape. This where nonparametric models becomes valuable in fitting dose-response
data where the parameters are unknown and the shape of the data is unpredictable.
The difficulty that faced the parametric model motivates us to develop a nonparametric model
that is more flexible in fitting unknown parameters and rough ”wiggly” data. Nonparametric regres-
sion is different than the parametric regression by that its capture unexpected feature of the data
uses a different shape of the functional relationship. The Nonparametric regression is a type of re-
gression analysis that known as a distribution-free with models that are infinite-dimensional, as in
the following format
yi = m(xi)+ εi, i = 1, ....,n
Where 0 ≤ x1 ≤ x2 ≤ .... ≤ xN ≤ 1 and the εi are independent draws from normal(0,σ2) with un-
known σ > 0 and m(.) is the unknown smooth and flexible function. Different types of nonpara-
metric modelling are introduced in Ruppert et al. [2003], ?, ? and ?, such as, regression splines,
smoothing splines, kernel methods including local regression, series-based smothers, and wavelets.
We are proposing a monotonic nonparametric model, which is flexible to fit the dose-response
data. Different non-parametric methods introduced to estimate the monotonic dose-response curve
using the bootstrap as Dilleen et al. [2003]. Delecroix et al. [1996] used the kernel method to
estimate the monotonic dose-response curve under general shape restriction. Out of all the non-
paramteric model types we consider the spline model. So we are developing a monotonic non-
paramtric model for a monotonic decreasing data. Spline is a nonparametric regression technique
that is written as a combination of basis function. It has a basis function representation which fits a
smooth curve between points in the data called the knots that is in the interval [L, U] with specific
constraints. All splines follows this model
yi = f (xi)+ εi, fi ∈ [0,1], i = 1,2, .....,n
where f (xi) is spline basis function and εi is the white noise Wegman and Wright [1983]. There
are many types of spline such as M, B, P, cubic, linear and quadratic spline for more about spline
types read Ruppert et al. [2006]. Every spline have t which are the set of basis functions that
connected linearly which differ in each spline. This article will contribute to a new monotonic
spline. Several monotonic splines are in the literature but our proposed spline is different as it has
specific constraints and it has a more general structure. I-splines is a monotone spline constructed
by a non-negative linear combination coefficient as Ramsay et al. [1988] who used the integrated
B-spline as basis function to maintain monotonicity. Ramsay et al. [1988] fitted the constrained
curve using non-Bayesian methods. He and Shi [1998] mentioned that I-spline faces uncertainty
when fitting it to real data. So,they proposed monotonic spline using a quadratic spline as the basis
function. An isotonic spline is a monotonic spline that depends on the cubic spline, and it’s non-
decreasing on a specific integral by certain constraints as mentioned in Wang and Li [2008]. Xue
and Wang [2010] moved to higher than the quadratic spline order using He and Shi [1998] methods,
which is computationally longer but they made monotonicity possible for any penalized splines (PS)
order. Each spline has its own knots, these knots are a sequence of points that divides the spline
interval to subintervals and its different in values and locations at different spline. It is known in the
literature that the spline smoothness is controlled by the number of knots and their locations, thus
number of knots are less than the data points. Knots have different selection methods; Wold [1974]
states some recommendation for knots selection, his recommendation are upon the assumption of
the cubic spline which needs modifications for a spline with degree greater than three. Cubic spline
frequently used since no lower degree spline can interpolate through data endpoints that have exact
derivative at each pointWolberg and Alfy [1999]. Knots have properties we introduce some here:
The knots are located on the data points. The Minimum of 4 to 5 observation should be between
knots. Knots should not have more than one extrema, and one inflection point, both should be
between knots. The extrema should be centred in the interval and inflection points should be close
to knots points.
A general introduction of the theory in interpolating and smoothing splines is given by Wasser-
man [2006] and Green and Silverman [1993]. DiMatteo et al. [2001] used fully Bayesian method
for curve fitting with free-knot splines using the reversible-jump Markov chain Monte Carlo as a
posterior sampling tool. Where the literature was studying the constraints on the parameters of
B-splines, Wood [1994] used piecewise polynomial properties of a spline with conditions on mono-
tonicity. That considered the cubic piecewise from Hyman [1983] and extends the work to the
cross-validation and confidence interval techniques.
Spline basis function known as
f (x) =
k
∑
i=1
aixi, i = 1, .....,n (1)
Where ai set of non negative weights sums up to one and xi are the spline basis function over
the knots Ki. Smoothing spline is a popular technique with spline usage in Silverman [1985] that
provide a review of all possible smoothing methods. We used a smoothing parameter to control
the smoothing fit of our proposed spline. Selecting the parameter something λ or the knots k is
crucial and differs in each spline. Different selection method are proposed in the literature as Xue
and Wang [2010] used AIC criteria to select the number of interior knots Kn. Fitting spline using
cross-validation was covered by Wahba and Wold [1975], a valid mean square error method used
to determine the correct degree of smoothing to a discrete data, and used Markov chain Monte
Carlo (MCMC) which is the Bayesian sampling method to estimate the true smooth function and
its derivative.
The test of monotonic regression function based on the critical bandwidth and the smoothing
level imposes the non-parametric estimate to be monotonic in Bowman et al. [1998]. Curves of
a dose response model estimated by contracting a combination of smoothing spline and the non-
negative properties of cubic B-spline was used as in Kong and Eubank [2006]. Our approach is
similar to Clyde and Wolpert [2007] where they used a regression function model as a linear com-
bination of kernels. However, they used the general Le´vy processes as the prior distribution on the
measure where we used the stick breaking prior distribution. Their approach also different than
ours, since they are not considering the monotone regression in their model constraint, along with
the utilization of a different processes. Another approaches that is similar is Bornkamp and Ick-
stadt [2009], but they used a monotone increasing function and the Two-Sided Power distribution
(TSP) as the spline bases function. They concluded that TSP is 10 to 15 times faster than using the
Beta distribution function, more on TSP is found inVan Dorp and Kotz [2002]. Many authors have
contributed to this area in the past. Smooth monotone functions and the properties are introduced
by Ramsay and Abrahamowicz [1989] such as the I-splines. I-spline is a monotone spline con-
structed by a non-negative linear combination coefficient constricted by Ramsay et al. [1988] who
used the integrated B-spline as basis function to maintain monotonicity. Users of non-parametric
smoothing techniques should utilize their judgement in deciding the estimated regression curve and
the smoothing level. The noise level which controls the smoothness of the curve is a subjective
decision as Ha¨rdle [1990] used a software result to subjectively determine the smoothing level.
Comparison of different non-parametric methods introduced in Bhattacharya and Lin.
We consider the Bayesian framework using a normal likelihood and stick breaking prior to
estimate the posterior predictive by the MCMC sampling method. In this paper, we proposed a
new non-parametric model as an alternative to the parametric model for cases where the parametric
models do not fit the data. In this research, a new spline model (AM-Spline) was developed, which
matches the pathological example well. The AM-spline was used as a dose-response model which
we develop an algorithm to define the tolerable region that contains the safest chemical dosage with
an acceptable side effects. Several researchers have discovered other approaches in isotonic regres-
sion with smoothing consideration. For instance, Wright et al. [1980], Mammen [1991], Ha¨rdle
[1990], Friedman and Tibshirani [1984], and Kim et al. [2018] who used the hierarchical Bayes
framework, and characterization of stick-breaking process that allows unconstrained estimation of
the monotone function. What motivated us is that all parametric and non-parametric models struggle
in fitting a sinuous monotonic decreasing data.
Method for non-parametric monotone based on Bayesian analysis using isotonic regression were
developed by Neelon and Dunson [2004], who defined the flat region of the dose-response curve
constructed using a piecewise linear model with restricted prior distribution, along with the latent
Markov process formulation that was used to simplify the computation and to form a smooth re-
gression line. Another approach is the Semiparametric, which was suggested for dose-response
analysis Wheeler and Bailer [2012]. A semiparametric estimation has a constrained shape, which
was introduced by Wu and Sickles [2018] for elasticity. They used penalized splines when apply-
ing the shape constraint on the fitted model, and their work was inspired by Ramsay et al. [1988].
Assumption of monotonicity on the dose-response curve, and continuous observation to define the
confidence bands for isotonic dose-response curves found by Korn [1982] is modified by Lee [1996]
while keeping monotonicity. Monotonic increasing function in the Bayesian framework considers
a mixture of triangular distribution with unspecified dimension during the analysis the method is
introduced by Perron and Mengersen [2001]. Their approach is not restricted to Bayesian, but could
have other applications in the frequentest perspective.
AM-spline is a spline model that accommodates and fits the unexpected rough monotonically
decreasing data. Our new novel spline works with any possible statistical distributions, that makes
it more adaptable to various data. In other words, it contributed to the dose-response model as we
introduce here.
This paper is organized as follows: Section 1.1, motivating example Section 3, contains the
prior distribution, posterior computation and BMD/BMDL. We applied our method to possible ap-
plication in Section 4, while conclusions and discussion are offered in Section 5.
1.1 Motivating Example
To motivate our approach, we reanalyzed the study of the Organophosphate Pesticide (OP) data
by Moser et al. [2005]. We will show that the AM-spline model fits the data adequately and will
compare it to other methods. A neurotoxic study was conducted using 349 rats to investigate the
effects of OP, which is a common active pesticide in agriculture. OP data represent the side effects
on the nervous system of the rats that have been measured and called the endpoints. Moser et al.
[2005] tested multiple neurotoxicity endpoints in which we only consider the Blood cholinesterase
(BloodCHE).
This endpoint was measured at the effect of two different pesticides Acephate (ACE) and Diazi-
non (DIA) with different level of doses. ACE dose level from 0 to 120 (mg/kg) and DIA dose level
from 0 to 250 (mg/kg).
Each pesticide was consumed by the rat and absorbed into their system while the other pesticide
had a dose level of zero. The continuous endpoint BloodCHE is measured and recorded from the
rats system. In our research we considered each pesticide dosage individually and BloodCHE end-
point measurement which is available for each rat. See Moser et al. [2005] for more details about
the data collection and measurement process. Figure 1 shows that the OP data is monotonically
decreasing. In panel (a) the OP data is considering the ACE pesticide. We see the data is mono-
tonically decreasing with variation at zero dosage and the remaining data are gradually decreasing,
most of the data are in the range of 0 to 0.7 percent to control. Panel (b) is the DIA pesticide data
which is dramatically decreasing with some variation at zero dosage; most of the data fall in the
range of 0 to 0.7 percent to control. The Figure shows that DIA data is denser then ACE data.
The x-axis is the chemical dosage and the y-axis is the percent to control which is the percent to
corresponding controls required to consider the variance of these controls. More about percent to
control in Feuerstein et al. [1997].
(a) (b)
Figure 1: OP Data Blood considering the Blood Cholinesterase (BloodCHE) endpoint. In panel
(a) is the ACE pesticide data and in panel (b) is DIA pesticide data, both data are monotonically
decreasing. The x-axis is the chemical dosage (mg/kg) and the y-axis is the percent to control which
is the percent to corresponding controls required to consider the variance of these controls.
Fitting a model allows us to identify the region of the safe dose level. Understanding this region
could help to address environmental public health questions, such as what is the safest dose of
pesticide? The literature describes many dose-response models that fit the type of data we have but,
to our best knowledge, none have used our proposed model with the specific constraints we have
and none have used it in dose-response perspective.
2. Methodology
2.1 Isotonic Regression
Isotonic Regression is an ordered set for the real numbers {y1,y2, .....,yn}. The difficulty is find-
ing {m1,m2, ...,mn} that minimizes the ∑1n(yi−mi)2 given the restriction m1 ≤ m2 ≤ ......≤ mn. A
different approach to find the solution to that problem has been discovered by Barlow and Brunk
[1972], yet their algorithm is complicated, with the basic idea introduced by Friedman and Tibshi-
rani [1984]. It depends on choosing the scatter plot points starting with yi then moving to the right
and stop at first place where yi > yi+1. When yi+1 does not meet the monotone assumption, then yi
and yi+1 will be replaced by their average
y¯ = (yi+ yi+1)/2.
After finding the average they move to the left to make sure yi−1 ≤ y¯ if not, they pulled yi−1 with y¯i
and y¯i−1 replacing the three with their average. They continued to the left until monotone assump-
tion is satisfied, then get back to the right. This process of pulling the first violated point, and using
the average of the two points is continued until reaching the right edge in Friedman and Tibshi-
rani [1984] the solution to the dual problem. The goal for that monotone process was a monotone
increasing process. Our goal is a monotone decrease so the difference will be that this monotone
assumption yi > yi+1, and ours is yi < yi+1.
A generalized monotonic model fitted to the Bayesian analysis using isotonic regression model
that was introduced by Holmes and Heard [2003]. In order to make inference on posterior param-
eters of interest they adopt MCMC to sample the space of unconstrained models by varying the
numbers and the location of points. Isotonic and antotonic are two different monotonically cases in
nonparametric, so we move onto the next subsection to the general monotonic regression.
2.2 Monotone Regression
A monotonic function is a function where it is either entirely increasing or decreasing. The model
for continuous and homoscedastic data
yi = µ(xi)+ εi, i = 1, .....,n (2)
where εi ∼ N(0,σ2) and µ(.) is a continuous monotonic. Variables xi have to be bounded between 0
and 1. Our continuous monotonic decreasing function is from zero to one. The µ0(.) here have the
following formula
µ(x) = β0+β1µ0(x) (3)
Where µ0(.) the probability distribution function of the continuous bounded variable between 0 and
1. β0 is the intercept that represent the response at 0 and on the other hand, β0+β1 represent the
response at 1. Many applications for β0 and β1 which have a clear cut interpretation, just as in the
dose response model β0 represent an inactive drug and β1 represent the maximum effect of the drug.
The probability distribution function µ0(.) prior is a discrete mixture of parametric distribution
function F(x,ζ) of bounded continuous variables on interval [0,1], with parameters ζ ∈ Ξ. So, the
model is
µ0(x) =
∫
Ξ
F(x,ζ)P(dζ)
where P is a discrete mixing distribution on Ξ Bornkamp and Ickstadt [2009]. The most used
random probability measure is the Dirichlet Process because it has reasonable analytical properties
for the density estimation. Bornkamp and Ickstadt [2009] used a general discrete random measure
introduced by Ongaro and Cattaneo [2004]. Ohlssen and Racine [2015] introduced the assumption
of Bayesian model averaging on an experiment that has a control treatment as monotonicity dose-
response model.
2.2.1 AM-Spline
In our proposed spline we picked a fixed λ and specific knots but the previous methods could be used
with other application. AM-spline is our novel approach, using the normal CDF. The probability
density function of the normal distribution with parameters µ and σ2 is given by
Normal∼ (µ, σ2)
f (x) =
1√
2piσx
exp(−(x−µ)
2
2σ2
),x > 0 (4)
And the base function for the AM-spline is
CDF(normal) =
1
2
[
1+ erf
(
x−µ
σ
√
2
)]
(5)
where
er f (x) =
2√
pi
∫ x
0
e−t
2
dt
The monotonic decreasing AM-spline is as the following
f(norm) =∑ai(1−F(x)), f (x) = (1−F(x)) (6)
Where ai are the weights and F(x) is the Normal CDF. The basis function could be any CDF of any
statistical distribution. Figure 2 represent the basis functions of AM-spline each curve is one base
function f (x) in equation 6.
Figure 2: Spline Basis Functions
General representation of the AM-spline in Figure 3, which show the monotonic decreasing
spline that fitted in the interval of [0,1] as the solid curve and the dashed line represent the ED50
under the fitted curve as if the spline used as a dose response model.
Figure 3: Fit of smooth monotonic decreasing function on the interval [0,1]. Two-dotted lines
define the tolerable area under the fitted model as the following, The dotted horizontal line in the
y-axis is the ED50 and the dotted vertical line in the x-axis is the dose correspond with the ED50
3. Bayesian Nonparametric
The Bayesian framework is the road to get the full distribution of the tolerable region and quantify
the uncertainty.
3.1 Prior Distribution
Considering Bayesian approach since it updates the belief of a study in the guise of new data,
where we could choose the prior and update the posterior distribution. We have our restriction in
the AM-spline so, our distribution is in the interval of [0,1]. Dirichlet Process (DP) is a random
probability distribution F that generated by a PD on any partition A1,A2, ....Ak of the sample space
which follows a Dirichlet distribution:
(F(A1), ....,F(AK)∼ D(a.F0(A1), ....,a.F0(Ak)).
Where its defined as F ∼ D(a,F0) and the parameters are the weight parameter a, and F0 the base
function. The DP is a stochastic process that used in Bayesian nonparametric models. It is the most
popular Bayesian nonparametric models and sometimes its called the ”distribution over distribu-
tions” since it can be thought as a distribution of probabilities themselves, and it has a variety of
application and methods. Zhou et al. [2018] used the Dirichlet Process in mixture model with latent
variables.
Dirichlet Process has several equivalent processes which could be a sampling methods such as:
po´lya urn, Chinese Restaurant Process, Hierarchical Dirichlet Process, Indian Buffet Process and
the Stick Breaking process ?. In this paper, we are using the Stick-Breaking techniques as it is a
representation of the DP. Our model has the Dirichlet distribution which is a generalization of the
Beta distribution into multiple dimensions. Beta distribution (α,β) is defined on (0,1) with density
as
f (x;α,β) =
Γ(α+β)
Γ(α)Γ(β)
xα−1(1− x)β−1
Note that if X ∼ Beta(a,b) then pi= (X ,1−X)∼ Dir(α) where α= [a,b]
In other words, it is a distribution over the (K-1) dimensional simplex, this distribution over the
value of K parameters who sum up to 1. It’s parametrized by the K-dimensional vector (α1,α2, ...,αK),
where αK ≥ 0 ∀ K and ∑K αK > 0. The distribution given by:
P(piK) =
∏KK=1Γ(α0)
Γ(∑KK=1αK)
K
∏
K=1
piαk−1K (7)
When pi ∼ (α1, .....αK) then piK ≥ ∀K, α0 = ∑ki=1αk and ∑KK=1piK = 1. The expectation of this
distribution is :
E[(pi1, ...,piK)] =
(α1, ...,αK)
∑K αK
(8)
Dirichlet distribution is a conjugate prior for the multinomial distribution, more about Dirichlet
Process prior in Ferguson [1973]. If pi∼ Dir(α1, ...,αK) and xn ∼Multi(pi) are iid samples then is:
p(pi|x1, ..,xn) ∝ p(x1, ...,xn|pi)p(pi)
=
(
∏KK=1Γ(αk)
Γ(∑KK=1αK)
K
∏
K=1
piαk−1K
)(
n!
m1!...mK!
pim11 ...pi
mK
K
)
∝ ∏
K
K=1Γ(αk +mk)
Γ(∑KK=1αK +mk)
K
∏
K=1
piαk+mk−1K
= Dirichlet(α1+m1, ...,αK +mK)
Where mk represent the counts of instances of xn = k in the data set. Variational inference
algorithm introduced by
Stick-breaking prior is a technique used to fit the posterior of Bayesian Nonparametric model
using a Gibbs samplers tool. Stick-breaking prior is similar to the discrete random probability
measures C, which has the general form
C(.) =
N
∑
k=1
akδQk(.), (9)
Where ak is the random weight, 0≤ ak ≤ 1 and ∑Nk=1 ak = 1. δQk(.) represent the discrete measure
at Qk with iid random assumption. 1≤ N ≤ ∞ where N could depend on the sample size n in some
cases and it could be finite or infinite. Equation 9 is similar to equation 1 but differ in the term of the
multiplied term. The random weight selection process is what distinguishes stick-breaking priories
apart from the general random measures C as in equation (9). If random probability measures or
stick breaking random measures is in the form of equation (9) then call C a CN(a,b) and
C1 = Z1 and Ck = (1−Z1)(1−Z2).......(1−Zk−1)Zk, k ≥ 2 (10)
Zk
ind∼ Beta(ak,bk), ak,bk > 0 where a as vector (a1,a2, ..) and b as vector as well (b1,b2, ...). Stick
breaking procedure could be in form of equation (10), the steps of stick breaking are considered
independent and random properties when breaking what is left of a stick, and specifying the length
of this break to the current Ck value. There is a long history of stick breaking weight determination
mentioned in Ishwaran and James [2001]. Two possible cases in stick breaking procedure
N <∞ and N =∞ both use Dirichlet distribution on the random weight and have been introduced
in Ishwaran and James [2001]. More literature in stick-Breaking could be found in Rodriguez and
Dunson [2011], Ishwaran and James [2003].
The posterior distribution is determined using the sampling method Metropolis Hasting (MH)
which was introduced by Hastings [1970]. We used the Stick-breaking prior in our method which
is a type of the MH sampling method. Nonparametric model consider the Dirichlet distribution and
its process which is a type of the Stick-Breaking process, as both used the beta-distribution random
variables with the weight that drawn simultaneously by MCMC scheme, as Kim et al. [2018] and
Lynch [2007] used in determining the prior and the posterior.
3.2 Posterior Computation
Having the Dirichlet distribution as a prior distribution of the multinomial parameters pi ∼ Dir(α)
and the posterior distribution is unknown. The parameters distribution are Dirichlet distribution
which is different from those on the prior distribution. That makes posterior calculation straightfor-
ward, but in our study, it is difficult to find the posterior distribution. Therefore MCMC sampling
methods are helpful in finding the predictive posterior distribution. The current observations are
X = {x1,x2, ....xN}, x˜ are the new observations (that the sampling method accept) and β are the
parameters.
p(x˜) =
∫
Θ
p(x˜|β,X)p(β|X)dβ (11)
Sampling algorithm:
At each data points (parameter) : We draw 10,000 MCMC samples for i=1,2,.... do
1. For the posterior distribution with parameter β drawn a sample βm
2. Stick-breaking is a sampling approach from Dirichlet process, which samples from thw
distribution over the space and the distribution drawn is discrete with probability 1. The
discrete distribution has a random probability mass function as
f (θ) =
∞
∑
k=1
βk.δθk(θ)
Where βk are a random weights chosen to be independent of θk so as 0≤ βk ≤ 1 and
∑∞k=1βk = 1. Whereas, δθk is an indicator function which is zero everywhere, except
δθk(θk) = 1
βk = β′k
k−1
∏
i=1
(1−β′i)
Where β′k are independent random variables with the beta distribution Beta(1,α). βk is the
length of the piece of a stick, process start with the stick unit-length and at each step stick
break off a portion uniformly of the remaining stick β′k then assign to the broken-off piece to
βk. Accepting new candidate points if 0 < β′ < 1
3. Posterior maintain the Dirichlet process constraints
end
More about both Gibbs sampling for stick-breaking prior given by Ishwaran and James [2001]
for MCMC methods by Hastings [1970].
3.3 BMD/BMDL estimation
Dose response model has several famous threshold such as the Bench mark dose (BMD) and the
No Observable Adverse Effect Level (NOAEL). Slob et al. [2005] provides a comparison between
BMD and NOAEL in multiple simulated studies. Bayesian BMD (BBMD) is a benchmark dose
technique that incorporates the prior information. This can lead to saving animals lives in a study
and improving the accuracy of the research Slob and Setzer [2014].
In this article the tolerable region is bounded by the ED50 threshold, the region of the safest dose
using the single chemical and the adverse effect. MCMC samples are across all possible models,
we use MH algorithm. The algorithm steps: the chain start with one set of mean µ1 in the simplest
model and the variance drawn from the prior. Change is then introduced to the model, the changes
are in adding a new set or rotating, change points or deleting existing set in the model. Accepted
changes have probability Q
Q = min
{
1,
p(β′|Y )S(β|β′)
p(β|Y )S(β′|β)
}
(12)
Where β is the model parameters current model and β′ is the new model with change parameters.
p(β|Y ) is the posterior probability for the model parameters β conditioning on the data. S is the
proposal distribution for the change parameters. When the changes are accepted then the chain
move to the new β′ and if not the chain stay at it’s study state β. These steps repeated for large
number of times to get a samples β1,β2, .....,βi. Success MCMC sampling method relays on the
proposal distribution S, where it is effective in alternate the dimension samplers. Since adding and
removing parameters from the model impact the likelihood of the new model Holmes and Heard
[2003].
4. Application
In this section, we will apply our proposed approach to evaluate its effectiveness on two simulated
datasets and to the OP data introduced in Section 1.1
4.1 Simulated Example
To assess the viability of our proposed technique we applied it to two simulated datasets named
{sim 1} and {sim 2}. These are pathological examples as they do not exhibit traditional parametric
model shapes. Sim 1 has 140 observations and Sim 2 has 234 observations. Figure 4 shows the
scatter plots of the two datasets; the x-axis is Dose, and the y-axis is the percent to control. In panel
(a) Sim 1, the percent to control data decreases linearly as dose increases from dosage 0 to 3. After
dosage of 3 the pattern levels out sharply to around 0.2. In panel (b) Sim 2 has multiple inflection
points at dosages 3, 5 and 7. The percent to control is near zero from dosages 7 to 10. Notice
that both of these simulated data are monotonically decreasing on the percent to control as the dose
increases.
(a) (b)
Figure 4: Two simulated datasets Sim 1 (a) and Sim 2 (b).
4.1.1 Sim 1 data analysis
To define the basis functions of the AM-spline model when applying it to the sim 1, we used the
following knots k={ 0, 0.1, 0.25, 0.5, 1,1.2, 2, 3, 4, 5, 6, 7, 10} and the bandwidth λ= 0.8. We con-
sidered the normal likelihood and on the ai parameters, the stick-breaking prior distribution on the α
parameters and chi-square distribution on the σ parameters with 2 degree of freedom. These priors
combined with the likelihood are used to draw samples of the parameters from posterior distribution.
The following parameters were estimated: the weights ai where ∑ki=1 ai = 1, the standard deviation
σ and the lower support α using MCMC sampling methods. Python 3.6 was used to implement the
sampling scheme which took 30 minutes to obtain the samples. The Metropolis-Hastings sampling
method was employed to obtain 10,000 MCMC samples. Before running a long chain from the
sampler we ran several short chains of 1,000 to tune the sampler and then discarded these samples
as burn-in samples. Table 1 shows the estimate summaries of the posterior parameter samples of α,
σ2 and the weights ai=k. This shows that there are three parameters with heavyweights at the two
knots (k = {0.5,2}) and the α. Fitting the AM-spline model to the simulated data sim 1 results in
the parameters estimate represented in Table 1 and the fit of the model in Figure 5, which shows
the AM-spline is fitted to Sim 1 data. In panel (a) the red solid line is the AM-spline mean, and
the dashed lines are the 0.025 and the 0.975 quantiles of the posterior predictive distribution. We
examined these convergence of the parameters of MCMC samples from the posterior distribution
by visual inspection of the trace plots. These samples are used to generate samples from posterior
predictive distribution which are then used to find the samples of the ED50 distribution. ED50 is the
dosage with the 50% corresponding response which define the tolerable region that calculated by
Equation (12). Panel (b) represents the histogram of the tolerable region and the vertical dashed line
on the histogram is the estimated ED50. This is calculated as the 0.05 quantile of the distribution
effective dose which is at Dose= 1.95. This demonstrates that the AM-spline is capable of finding
an ED50 for sim 1.
Sim 1 is a fast decreasing simulated data that could exist in the toxicology lab. Determining a
dose-response model for such data is difficult since no parametric or nonparametric model has this
type of function. AM-spline fits Sim 1 data adequately as shown in the Figure and table below.
Table 1: Sim 1 Parameter estimates for the AM-Spline based on 10000 MCMC samples from the
posterior distribution, λ= 0.8, σ= 0.001 and knots at k = {0,0.1,0.25,0.5,1,1.2,2,3,4,5,6,7,10}
Parameter Mean Median StDev 95% Credible interval
α 0.1989 0.1989 0.0017 ( 0.1978, 0.2022)
σ2 0.0002 0.0002 0.00003 (0.0002, 0.0003)
a1 (k = 0) 0.0179 0.0142 0.0148 (0.0062, 0.0513)
a2 (k = 0.1) 0.0307 0.0246 0.0261 (0.0102,0.0930)
a3 (k = 0.25) 0.0541 0.0494 0.0372 (0.0238,0.1307 )
a4 (k = 0.5) 0.2287 0.2322 0.0434 (0.1989,0.3032 )
a5 (k = 1) 0.0157 0.0109 0.0148 (0.0046,0.0528 )
a6 (k = 1.2) 0.0097 0.0067 0.0096 (0.0028,0.0354 )
a7 (k = 2) 0.6166 0.6170 0.0198 (0.6027,0.6523 )
a8 (k = 3) 0.0236 0.0242 0.0118 (0.0143,0.0444 )
a9(k = 4) 0.0013 0.0008 0.0015 (0.0003,0.0052)
a10 (k = 5) 0.0012 0.0008 0.0012 (0.0003,0.0042 )
a11 (k = 6) 0.0003 0.00008 0.0005 (0.00001,0.0017 )
a12(k = 7) 0.0002 0.00003 0.0005 (0.000008,0.0018)
a13 (k = 10) 0.00001 0.000005 0.00001 (0.0000003,0.0001)
(a) (b)
Figure 5: Panel (a) AM-spline model fitted to the simulated Sim 1, the solid line represents the fit
of the AM-spline and the dotted lines are the credible intervals. Panel (b) histogram represents the
samples of the tolerable region and the vertical dashed line represents the ED50.
4.1.2 Simulated Data 2 (Sim 2)
In our second simulated data sim 2. We defined the basis functions of the AM-spline by the follow-
ing knots k = {0,3,6} and the bandwidth λ = 0.5. In sim 2 we used the exact same techniques as
in sim 1, the only different was the type of data we have and the number of knots we used in sim
2. The data Sim 2 has more inflection points than in Sim 1, so that makes them different than each
other.
We considered the normal likelihood and the stick-breaking prior distribution on the ai parame-
ters, the normal prior distribution on the α parameter, and chi-square distribution on the σ parame-
ters with 2 degree of freedom. These priors combined with the likelihood are used to draw samples
of the parameters from the posterior distribution. The following parameters: ai are the weights
where ∑ki=1 ai = 1, σ is the standard deviation and α is the lower support, were estimated using the
MCMC sampling methods. Python 3.6 was used to implement the sampling scheme which took 30
minutes to obtain the samples. The Metropolis-Hastings sampling method was employed to obtain
10,000 MCMC samples. Before running a long chain from the sampler we ran several short chains
of 1,000 to tune the sampler and then discarded these samples as burn-in samples. Fitting the AM-
spline model to the simulated data sim 2 results in the parameters estimate represented in Table 2
and the fit of the model in Figure 6. Table 2 shows the summaries of MCMC parameter samples
α, σ2 and ai=k, which shows that AM-spline is fitted to Sim 2 data adequately and we see that two
of the knots have heavyweights at (k = {3,6}). Figure 5 in panel (a) the red solid line is the AM-
spline mean, and the dashed lines are the 0.025 and the 0.975 quantiles of the posterior predictive
distribution. Since the fitted model is an adequate than the distribution of the tolerable region is
calculated as in (4.1.1). We examined these convergence of the parameters of MCMC samples from
the posterior predictive using the trace plots by visual inspection. These distribution samples were
then of the tolerable region is defined by Equation (12) which determines the ED50 dosage and the
corresponding response across all MCMC samples. Panel (b) represent the histogram of the toler-
able region, and the vertical dashed line on the histogram is the estimated ED50; which calculated
as the 5% quantile of the distribution effective dose which is at Dose= 5.68. This demonstrates that
the AM-spline is capable of finding an ED50 for sim 2.
Sim 2 is an example of a wiggle data that could exist in the toxicology lab. Determining a dose-
response model for such data may be challenging, AM-spline fits Sim 2 data adequately as shown
in the Figure and table below.
Table 2: Sim 2 Parameter estimates for the AM-Spline based on 10000 MCMC samples from the
posterior distribution, λ= 0.5 and knots at k = {0,3,6}
Parameter Mean Median StDev 95% credible interval
α 0.0523 0.0523 0.0011 ( 0.0515, 0.0545)
σ2 0.0001 0.0001 0.0001 (0.0001, 0.0002)
a1 (k = 0) 0.0488 0.0488 0.0014 (0.0478, 0.0514)
a2 (k = 3) 0.3243 0.3243 0.0023 (0.3228,0.3285 )
a3 (k = 6) 0.6269 0.6269 0.0017 (0.6258,0.6301 )
(a) (b)
Figure 6: Panel (a) AM-spline fitted model to the simulated Sim 2, the solid line represents the fit
of the AM-spline and the dotted lines are the credible intervals and in panel (b) histogram represents
the samples of the tolerable region and vertical dashed line represents the corresponding dose to the
ED50.
From Figures 5 and 6, we see that AM-Spline smoothly fit the data precisely where other model
fail to fit the data as perfect as the AM-spline model, that is in the best of our knowledge. In Sim
2 the tolerable region is smaller than Sim 1 and that affected by the number of observation and
numbers of knot. In sim 1 and sim 2 there are two knots that have a heavy weight.
4.2 Organophosphate Data
The US EPA is interested in researching the effects of exposure to pesticides, especially Organophos-
phates (OP) such as Acephate (ACE) and Diazinon (DIA). Moser et al. [2005] conducted a labo-
ratory study looking at Blood Cholinesterase as the endpoint when rats were dosed with these two
chemicals more about the data in section 1.1. In this section, we Applied the univariate AM-spline
model to the collected data. The goal here is to evaluate the effectiveness and the efficiency of
AM-spline model and detriment the ED50 in existing data.
4.2.1 ACE data
The AM-spline model requires determining the smoothing parameter (bandwidth) λ, the set of knots
and the stander deviation for each data. We fitted the following bandwidths:{2,6,10,20} to deter-
mine the ideal bandwidth for the ACE data. From figure 7 different bandwidth have been fitted to
the ACE data, x-axis is the chemical doses and the y-axis is percent to control. The figure shows
that when the bandwidth increases the smoothness of the model increases and when the bandwidth
exceeds the data limit, the fitted model no longer fits the data well. Consequently, we picked λ= 10
and The knots chosen randomly in the range of the data values, when fitting AM-spline model in this
application. Since we are using the Metropolis Hastings algorithm and we use different coefficient
step value when changing the bandwidth.
Figure 7: Comparing the fit of AM-spline model when considering the following four bandwidth
{λ = (2,6,10,20)}. We found λ = 10 matched the data the most, so we used λ = 10 as our band-
width in this research
Applying the AM-spline to the ACE data using λ= 10, and the knots as k= {0,5,9,15,30,60,120}.
The fit of the model will produce a parameters estimate and posterior predictive distribution. There-
fore, we assumed normal likelihood, stick breaking prior in the weights parameters ai, the normal
prior on the lower support α and the chi-square prior in the stander deviation σ. To determine the
posterior distribution we use the MCMC sampling tool to draw samples from the combined likeli-
hood and priors. Using python 3.6 which takes 45 minutes to obtain the samples. The Metropolis-
Hastings sampling method used to obtain 10,000 MCMC samples. Before running a long chain
from the sampler, we ran several short chains of 1,000 to tune the sampler and then discarded these
samples as burn-in samples. Parameters estimate presented in table 3 which shows the estimate
summaries of the posterior parameter samples of α, σ2 and the weights ai=k. This table shows that
there are three parameters with heavyweights at the knots (k = {15,30}) and the α. and figure 8 is
the result of fitting the model to the data. Fitting the AM-spline model to the simulated data Sim 1
results in the parameters estimate represented in Table 3 and the fit of the model in Figure 8, which
shows the AM-spline is fit to ACE 1. In panel (a) the red solid line is the AM-spline mean, and
the dashed lines are the 0.025 and the 0.975 quantiles of the posterior predictive distribution. We
examine these convergence of the parameters of MCMC samples from the posterior distribution by
visual inspection of the trace plots. These samples were then used to generate samples from pos-
terior predictive distribution, which are used to find the samples of the ED50 distribution. ED50 is
the dosage with the 50% corresponding response, which define the tolerable region that is calcu-
lated by Equation (12). Panel (b) represents the histogram of the tolerable region, and the vertical
dashed line on the histogram is the estimated ED50. This is calculated as the 0.05 quantile of the
distribution effective dose which is at Dose = 18. This demonstrates that the AM-spline is capable
of finding an ED50 for ACE data.
Table 3: ACE data Parameter estimates for the AM-Spline fit considering 10,000 MCMC samples
from the posterior distribution with λ= 10 and knots at k = {0,5,9,15,30,60,120}
Parameter Mean Median StDev 95% credible interval
α 0.1776 0.1830 0.0576 ( 0.1409, 0.2742)
σ2 0.0212 0.0210 0.0030 (0.0190, 0.0276)
a1 (k = 0) 0.0226 0.0180 0.0197 (0.0082, 0.0696)
a2 (k = 5) 0.0476 0.0350 0.0439 (0.0153, 0.1547)
a3 (k = 9) 0.1024 0.0819 0.0853 (0.0343, 0.3100)
a4 (k = 15) 0.5341 0.5487 0.1700 (0.4214, 0.8265)
a5 (k = 30) 0.1660 0.1374 0.1280 (0.0618, 0.4560)
a6 (k = 60) 0.0846 0.0692 0.0693 (0.0265, 0.2394)
a7 (k = 120) 0.0427 0.0216 0.0521 (0.0056, 0.1840)
(a) (b)
Figure 8: Panel (a) AM-spline fitted to the ACE data as the solid line and the two dashed lines are
the credible intervals and in panel (b) is the ACE-histogram of the samples of the tolerable region
with the dashed line that represents the corresponding dose to the ED50, the stressor (ACE) and the
endpoint (BloodCHE).
4.2.2 DIA data
DIA is the second pesticide in OP data, DIA data is second real data application to our model.
Applying AM-spline to DIA data require using a specific smoothing parameter (bandwidth). We
examine the following bandwidth :{2,6,10,20} to determine the ideal bandwidth for the DIA data
and we picked λ= 10 since it fit the data the most. Am-spline fit the data considering λ= 10 and the
following knots k = {0,5,9,15,30,60,120,150,250} which are in the data points. We have the fol-
lowing parameters that will be estimated: ai are the weights parameters that have the stick breaking
prior. α the lower support parameter that has a normal prior and the stander deviation σ parameter
which has the chi-square prior with 2 degree of freedom. Combining the normal likelihood with
the priors to draw samples using MCMC to define the predictive posterior distribution. The MH
sampling algorithm used to obtain 10,000 MCMC samples. Before running the full MCMC chain,
we run several shorter chains of 1,000 samples to tune the samples and we discard them as a burn-
in samples. After fitting the model to the data using the provide information we get the following
Table 4 and Figures 9. Parameters estimate summaries of MCMC samples presented in Table 4 the
ai = k, α and σ. The table shows that two knots have heavy weights at (k = {9,15}). Figure 9 shows
the fit of AM-spline model as in panel (a) the red solid line is the AM-spline mean, and the dashed
lines are the 0.025 and the 0.975 quantiles of the posterior predictive distribution. We examine these
convergence of the parameters of MCMC samples from the posterior distribution by visual inspec-
tion of the trace plots. These samples were then used to generate samples from posterior predictive
distribution, which are used to find the samples of the ED50 distribution. ED50 is the dosage with
the 50% corresponding response, which define the tolerable region that is calculated by Equation
(12). Panel (b) represents the histogram of the tolerable region, and the vertical dashed line on the
histogram is the estimated ED50. This is calculated as the 0.05 quantile of the distribution effective
dose which is at Dose = 20. This demonstrates that the AM-spline is capable of finding an ED50 for
ACE data.
Table 4: Parameter estimates for the AM-Spline considering 10,000 MCMC samples from the
posterior predictive distribution using λ= 10 and the knots k = {0,5,9,15,30,60,120,150,250}.
Parameter Mean Median StDev 95% credible interval
α 0.0727 0.0736 0.0282 ( 0.0538, 0.1232)
σ2 0.0292 0.0287 0.0038 (0.0265, 0.0374)
a1 (k = 0) 0.0316 0.0236 0.0275 (0.0101, 0.0986)
a2 (k = 5) 0.0821 0.0569 0.0723 (0.0240, 0.2415)
a3 (k = 9) 0.3654 0.3783 0.1696 (0.2650, 0.6522)
a4 (k = 15) 0.3591 0.3426 0.1712 (0.2444, 0.7080)
a5 (k = 30) 0.1182 0.1177 0.0544 (0.0769, 0.2257)
a6 (k = 60) 0.0331 0.0195 0.0372 (0.0072, 0.1338)
a7 (k = 120) 0.0039 0.0013 0.0052 (0.0002, 0.0170)
a8 (k = 150) 0.0018 0.0009 0.0024 (0.0002, 0.0087)
a9 (k = 250) 0.0048 0.0015 0.0065 (0.0001, 0.0201)
(a) (b)
Figure 9: Panel (a) AM-spline fitted to the DIA data and in panel (b) histogram of ED50, the stressor
(DIA) and the endpoint (BloodCHE)
From figure 8 and 9 we see that the proposed model fit smoothly and perfectly to the two
different data. In ACE the tolerable region is wider and high in magnitude compared to DIA and
that affected by the range of the data.
4.3 Different ED’s
From the above applications, we could calculate the following table of ED90, ED75 and ED50 for
each data individually. Since ED90 and ED75 are out of the dosage range, we found that ED90 can
not be determined or calculated for DIA data, data1 and data2. So that tells us not all ED′s are
possible to find, it depends on the available doses. In the other hand, ED75 could be determined or
calculated for data1 and data2, could be determined or calculated for data1 and data2, since the data
has that possible doses. All ED’s present in the following Table 5.
Table 5: Different Effective Dose at each data set
Data ED Dose 90%CI
ACE
ED50 114.7147 (90.451, 119.760)
ED75 39.7598 (18.258, 67.508)
ED90 17.5375 (11.532,23.303)
DIA
ED50 21.5215 (13.501, 191.016)
ED75 7.5075 (3.003, 10.010)
ED90 NA (, )
data1
ED50 5.9459 (5.275, 6.006)
ED75 N/A (,)
ED90 N/A (,)
data2
ED50 5.8559 (5.696, 6.116)
ED75 N/A (,)
ED90 N/A (,)
4.4 Comparing AM-spline to Parametric methods
Previous work has covered the parametric dose-response model Logistic, Gompertz, Gaussian. Our
novel approach is the AM-spline for non-parametric dose-response model. Each model has a differ-
ent representation so, which dose-response model performer better in fitting the most of the data?
We used ACE data to answer this question, by fitting the different dose response models to the data.
Figure 10 shows the different fit of the models, x-axis the ACE dosage and the y-axis is percent to
control. Our fitted model the AM-spline is the bold dashed line in figure 10, and it fit the data well.
Whereas the other models performed considerably, but it did not fit the data well. For comparison,
we randomly chose Sim 2 and the DIA data to compare the performance of the AM-spline along
with other known parametric and nonparametric models. In Figure 11 the different models are fitted
to sim 2 as in panel (a) and to the DIA data as shown in panel (b), models are in different lines
and colors. The bold dashed red line in the AM-spline model, it preform well in matching the data.
Other models did not behave well and they were away from the data.
Figure 10: Gompertz, Logistic, Gaussian, Exponential, I-Spline and AM-Spline fitted to the OP
data with ACE as the stressor and the endpoint BloodCHE as the response.
in Figure 11 we also compared the ED50 for each data. The ED50 for the chemicals using
different models in different data From figure 11 panel (c), we see the Gompertz model has ED50 =
3.3 ,AM-spline and Gaussian models are performing at dose 4.5. On the other hand, ED50 for the
Logistic model is at dose 4.9 and the I-spline model is at dose 5.8. In panel (d), the AM-spline is
performing better than the Logistic and the Gaussian since it has a lower dose at 10. Whereas, the
Gompertz and the I-spline model are very close to the zero dose, which doesn’t show the complete
effect of the chemical. Therefore, AM-spline is minimizing the ED50 dose and the adverse effect as
well.
(a) (b)
(c) (d)
Figure 11: ED50 tolerable regions for Logistic, Gompertz, Gaussian, I-spline and AM-Spline for
sim 2 data in panel (a) and panel(b) is the DIA data represent the endpoint BloodCHE. Vertical lines
represent the ED50 for each models in panel (c) and (d).
5. Conclusions and Discussion
In this article, a new monotonic spline has been presented. We found that constrained smoothing
splines are useful since we can customize the methods to any specific study and could choose the
proper smoothing parameter λ. Our nonparametric monotonically decreasing spline is flexible and
effective in different statistical approaches and applications. Analysis and computation of nonpara-
metric models are handier as mentioned in the literature The process and the fit of the model are
sensitive to multiple properties: the step value, the size of the MCMC sample, the sampling start-
ing value effect, the number of knots and the smoothing value. Our approach is producing new
spline (AM-spline) with constraints on the distribution with values between zero and one. Fitting
of the dose-response model to toxicology experiment was used to determine the tolerable region
that defines the safest dose combination. We limited the scope of this paper to the AM-spline in-
troduction and there are more possible approach that could be developed in the future such as the
penalized residual sum of square, experimental design approach, applied to different parameter se-
lection method, spatially adaptive model and could be used as a model in the optimal follow-up
design criteria.
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